Lorena Alarcon-Casas Wright, MD
Metabolism, Endocrinology and Nutrition
Clinical Assistant Professor
Dr. Wright received her medical degree from the University of Veracruz in Mexico. She completed one year of internship in Medicine in Mexico and worked at a rural clinic caring for an underserved population with chronic disorders including diabetes and obesity. She completed her internal medicine residency at Cottage Hospital in Santa Barbara, California, a community hospital affiliated to the University of Southern California. During her residency, Dr. Wright participated in research projects at the Sansum Diabetes Research Institute and at the Santa Barbara Diabetes-in-Pregnancy County Clinic.
Dr. Wright came to the University of Washington to fulfill her dream of becoming an endocrinologist and diabetologist. She completed a three-year research fellowship in Endocrinology, Nutrition and Metabolism and became a Clinical Assistant Professor in 2012.
Dr. Wright enjoys teaching endocrine fellows, residents and medical students through the UW fellowship program. In addition to clinical teaching and patient care responsibilities at the University of Washington Medical Center, Harborview Medical Center and The Diabetes Care Center, Dr. Wright participates in mentoring minority pre-med and medical students through the Underrepresented Medical Students (URM), the Center for Equity, Diversity, and Inclusion (CEDI) and the Office of Graduate Medical Education (GME) of the University of Washington.
Dr. Wright’s clinical work focuses on endocrinology care at the UWMC and Harborview clinics; and diabetes care at the Diabetes Care Center.
Dr. Wright’s research interests are in the areas of pre-diabetes, glycemic control and glycemic markers in diabetes and pregnancy complicated by diabetes. Dr. Wright is particularly interested in strategies to prevent and delay the progression of diabetes.
Faulenbach MV*, Wright LA*, Lorenzo C*, Utzschneider K, Goedecke J, Fujimoto W, Boyko E, McNeely M, Leonetti D, Haffner S, Kahn SE, and American Diabetes Association GENNID Study Group: Impact of Differences in Glucose Tolerance on the Prevalence of a Negative Insulinogenic Index. The Journal of Diabetes and its Complications. IN PRESS *contributed equally
Published online 08 November 2012
Wright, LA, Hirsch I. The Challenges of the Use of Glycemic Biomarkers in Diabetes Monitoring. Reflecting on Hemoglobin A1C, 1,5-Anhydroglucitol, and the Glycated Proteins. Diabetes Spectrum 2012; 25: 141-148
Kahn SE, Suvag S, Wright LA, Utzschneider KM. Interactions Between Genetic Background, Insulin Resistance and Beta-cell Function. Diabetes, Obesity and Metabolism 2012; 14:46-56
Smits M, Boyko E, Utzschneider K, Leonetti D, McNeely M, Suvag S, Wright LA, Fujimoto W, Kahn SE: Arm Length is Associated with Type 2 Diabetes Mellitus in Japanese Americans. Diabetologia 2012; 55: 1679-1684
Marina A, Utzschneider K, Wright LA, Montgomery B, Marcovina S, Kahn SE: Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and Beta-Cell Function. Diabetes Care 2012; 35: 1119-1125
Trujillo A, Wright LA, Jovanovic L: Medical Management of Preexisting Diabetes in Pregnancy, in the book Diabetes In Women. Pathophysiology and Therapy 2010.